Anzeige
Mehr »
Login
Mittwoch, 28.07.2021 Börsentäglich über 12.000 News von 669 internationalen Medien
Ausbruch nach Auszeichnung - Startet jetzt die NASDAQ-Rallye?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU8Q ISIN: CA74141E1043 Ticker-Symbol: 18H 
Tradegate
27.07.21
21:41 Uhr
0,018 Euro
-0,001
-3,23 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREVECEUTICAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
PREVECEUTICAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0170,02027.07.
0,0150,02227.07.

Aktuelle News zur PREVECEUTICAL MEDICAL Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.07.Preveceutical Medical Inc: Preveceutical files int'l patent for dynorphin peptides10
07.07.PreveCeutical Medical Inc.: PreveCeutical Files International Patent Application for its Dynorphin Peptides163Vancouver, British Columbia--(Newsfile Corp. - July 7, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has filed...
► Artikel lesen
PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln
31.05.Preveceutical Medical Inc: Preveceutical Medical appoints three advisers8
31.05.PreveCeutical Medical Inc.: PreveCeutical Provides Corporate Update315Vancouver, British Columbia--(Newsfile Corp. - May 31, 2021) - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is pleased to provide the following...
► Artikel lesen
15.03.Preveceutical Medical Inc: Preveceutical appoints RAS founder, CEO Bahl as adviser11
13.03.PreveCeutical Medical Inc.: PreveCeutical Announces Debt Settlement and Conversion of Debt747Vancouver, British Columbia--(Newsfile Corp. - March 12, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that it has agreed to...
► Artikel lesen
13.03.Preveceutical Medical Inc: Preveceutical to issue 19.55M debt shares, convert debt4
23.02.PreveCeutical Medical Inc.: Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical301Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is very pleased to announce...
► Artikel lesen
02.02.Preveceutical Medical Inc: Preveceutical completes analgesic program20
05.01.PreveCeutical Medical Inc.: PreveCeutical files Provisional Patent Application for its BSV Peptide499Vancouver, British Columbia--(Newsfile Corp. - January 5, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has...
► Artikel lesen
25.11.20PreveCeutical Medical Inc.: Successful Completion of the COVID-19 Sol-Gel Formulation Development315Vancouver, British Columbia--(Newsfile Corp. - November 25, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to announce the successful laboratory...
► Artikel lesen
23.11.20PreveCeutical Files Provisional Patent Application for its COVID-19 Formulation312Vancouver, British Columbia--(Newsfile Corp. - November 23, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has...
► Artikel lesen
10.11.20PreveCeutical Provides Update on Its COVID-19 Cannabinoid Sol-Gel Program378Vancouver, British Columbia--(Newsfile Corp. - November 10, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to provide an update on its COVID-19...
► Artikel lesen
01.10.20Veteran Johnson & Johnson Executive Dr. Ajit Shetty Joins PreveCeutical901Vancouver, British Columbia--(Newsfile Corp. - October 1, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is very pleased to announce the...
► Artikel lesen
08.09.20PreveCeutical Provides Lead Pain Management Peptides Update565Vancouver, British Columbia--(Newsfile Corp. - September 8, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide a further...
► Artikel lesen
02.09.20PreveCeutical Announces Lead Pain Management Peptides Identified for Preclinical Evaluation378Vancouver, British Columbia--(Newsfile Corp. - September 2, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide an update...
► Artikel lesen
31.08.20PreveCeutical Files an Application for a Provisional Patent for Sol-gel Cannabinoids395Vancouver, British Columbia--(Newsfile Corp. - August 31, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has filed...
► Artikel lesen
17.08.20PreveCeutical Receives AU$1,227,902 Research & Development Tax Incentive Cash Refund451Vancouver, British Columbia--(Newsfile Corp. - August 17, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1